Analysis: Brooks Laboratories Limited

NSE:BROOKS Pharmaceuticals Bulk Drugs & Formulation Market cap: ₹193 cr

Research report

companyname: Brooks Laboratories Limited ticker: BROOKS sector: Pharmaceuticals Brooks Laboratories Limited is a pharmaceutical company with a single manufacturing facility at Baddi, Himachal Pradesh. It was incorporated on 23rd January, 2002. The company makes finished drug formulations across multiple dosage forms, including Beta-lactam tablets, Beta-lactam dry syrups, general injections, liquid injections, dry powder injections, eye and ear drops, oncology products, and hormonal injections. ...

Read the full report →
RS rating: 69 Stage: Stage 3

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Brooks Laboratories Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.